Catalyst Funds Management Pty LTD Exact Sciences Corp Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 10,500 shares of EXAS stock, worth $604,275. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,500Holding current value
$604,275% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.02 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$912 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$825 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$694 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$384 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.2B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...